Therapeutic Asset Ratings

272 results matching 1 filter

128,359 assets · 8,667 sponsors · 3,127 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Defactinib pancreatic adenocarcinoma	Washington University School of Medicine	P2	CCC (53)
Denosumab Dense Breasts	Washington University School of Medicine	P2	CCC (53)
Empagliflozin HER2+ Breast Cancer	Washington University School of Medicine	P2	CCC (53)
Evomela autoimmune lymphoproliferative syndrome	Washington University School of Medicine	P2	CCC (53)
Evomela hemophagocytic syndrome	Washington University School of Medicine	P2	CCC (53)
Evomela hyper-IgM syndrome	Washington University School of Medicine	P2	CCC (53)
Evomela Bruton-type agammaglobulinemia	Washington University School of Medicine	P2	CCC (53)
Evomela X-linked lymphoproliferative syndrome	Washington University School of Medicine	P2	CCC (53)
FDOPA Hyperinsulinism	Washington University School of Medicine	P2	CCC (53)
FLAVONE, 3,3',4',5,7-PENTAHYDROXY- premature aging syndrome	Washington University School of Medicine	P2	CCC (53)
FLAVONE, 3,3',4',5,7-PENTAHYDROXY- early-onset autosomal dominant Alzheimer disease	Washington University School of Medicine	P2	CCC (53)
FLAVONE, 3,3',4',5,7-PENTAHYDROXY- major depressive disorder	Washington University School of Medicine	P2	CCC (53)
Fludarabine autoimmune lymphoproliferative syndrome	Washington University School of Medicine	P2	CCC (53)
Fludarabine Bruton-type agammaglobulinemia	Washington University School of Medicine	P2	CCC (53)
Fludarabine X-linked lymphoproliferative syndrome	Washington University School of Medicine	P2	CCC (53)
Fludarabine X-Linked Lymphoproliferative Syndrome	Washington University School of Medicine	P2	CCC (53)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER autoimmune lymphoproliferative syndrome	Washington University School of Medicine	P2	CCC (53)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER hemophagocytic syndrome	Washington University School of Medicine	P2	CCC (53)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER hyper-IgM syndrome	Washington University School of Medicine	P2	CCC (53)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Bruton-type agammaglobulinemia	Washington University School of Medicine	P2	CCC (53)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER X-linked lymphoproliferative syndrome	Washington University School of Medicine	P2	CCC (53)
Levonorgestrel endometrial disorder	Washington University School of Medicine	P2	CCC (53)
Levonorgestrel Endometrial Neoplasm Malignant	Washington University School of Medicine	P2	CCC (53)
Levonorgestrel endometrial carcinoma	Washington University School of Medicine	P2	CCC (53)
PANTOPRAZOLE carcinoma of the ampulla of vater	Washington University School of Medicine	P2	CCC (53)

Showing 76 to 100 of 272 assets

PreviousPage 4 of 11Next